 Silence Therapeutics PLC has teamed up with one of Chinas biggest drug developers in a deal that could be worth US1.3bn in milestone payments. The UK gene silencing specialist will receive an upfront US16mln as part of the collaboration agreement with Hansoh Pharma. 